2016 Production Schedule

2016 Production Schedule
Trialscape maps are published based on
all trial timing projections. We also offer
Citeline’s editorial calendar to accommodate
discounted Full Portfolio pricing that includes
the inclusion of data from major conferences
access to every map included in the therapeutic
and anticipated industry events.
area. Upon purchase, all Trialscape maps are
You may purchase Trialscape maps singly or
as annual subscriptions that include a base
map plus two updates (for a total of three
releases). Every update involves a full
reassessment of the trials landscape and
includes the addition of all new trials that fit
the map criteria and full review/analysis of
made available enterprise-wide for download
through Trialtrove.
For interest in areas beyond this list, customized
options are available. Our analysts will work
with you to create a deliverable that is tailored
to your needs. To order, contact your account
manager or email analytics@citeline.com.
Please note that Citeline updates the Trialscape inventory map selection and content annually, based on industry interest and activity, and may edit the
scope of specific maps between releases, based on area growth and other considerations.
AUTOIMMUNE/INFLAMMATION
Biosimilars of Adalimumab in Autoimmune/Inflammation, All Phases
Feb-16
Jul-16
Feb-17
Pipeline Biologics in Psoriasis, Phase III
Apr-16
Oct-16
Apr-17
Pipeline Biologics in Asthma, Phase III
Jun-16
Oct-16
Jun-17
Pipeline Biologics in Rheumatoid Arthritis, Phase III
Jul-16
Nov-16
Jul-17
Pipeline Kinase Inhibitors in Rheumatoid Arthritis, Phases II - III
Jul-16
Nov-16
Jul-17
Pipeline Drugs for Congestive Heart Failure, Phase III
Apr-16
Oct-16
Mar-17
Select Pipeline drugs for Dyslipidemia, Phase III
Apr-16
Oct-16
Mar-17
Pipeline Drugs for Pulmonary Hypertension, Phase III
Apr-16
Oct-16
Mar-17
Beta Amyloid Antagonists/Inhibitors in Alzheimer’s Disease, Phase III
Apr-16
Nov-16
Apr-17
Oral Agents in Multiple Sclerosis, Phases II - III
May-16
Nov-16
May-17
Chronic Neuropathic Pain, Phase III
Jun-16
Oct-16
Jun-17
Pipeline Drugs for Respiratory Synctial Virus, Phase II-III
Feb-16
Oct-16
Feb-17
HCV Direct Acting Antivirals (DAAs) - Combination Trials, Phase III
May-16
Dec-16
May-17
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
INFECTIOUS DISEASE & GENITOURINARY
2016 Production Schedule
METABOLIC/ENDOCRINOLOGY
Pipeline Drugs for Chronic Renal Anemia, Phase II
Feb-16
Sep-16
Feb-17
Pipeline Drugs for Chronic Renal Anemia, Phase III
Feb-16
Sep-16
Feb-17
Type 2 Diabetes CV Outcomes, All Phases
Feb-16
Sep-16
Feb-17
Breast Cancer First Line Therapies, Phase III & Pivotal Phase II
Jan-16
Jul-16
Jan-17
Breast Cancer Second Line or Greater Therapies, Phase III & Pivotal Phase II
Jan-16
Jul-16
Jan-17
Hormone Refractory Prostate Cancer Therapies, Phase III & Pivotal Phase II
Feb-16
Aug-16
Feb-17
Pancreatic Cancer Therapies, Phase III & Pivotal Phase II
Feb-16
Aug-16
Feb-17
Melanoma Therapies, Phase III & Pivotal Phase II
Mar-16
Sep-16
Mar-17
Ovarian Cancer Therapies, Phase III & Pivotal Phase II
Mar-16
Sep-16
Mar-17
Non-Small Cell Lung Cancer Immunotherapies, Phase III & Pivotal Phase II
Apr-16
Oct-16
Apr-17
ONCOLOGY
www.citeline.com
Citeline © 2016. All rights reserved.